Pacheco André P, Cedernaes Jonathan, Benedict Christian
Department of Research and Innovation, Division of Mental Health and Addiction, Oslo University Hospital, Sognsvannsveien 21, Oslo, 0372, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Curr Psychiatry Rep. 2024 Dec;26(12):703-711. doi: 10.1007/s11920-024-01546-9. Epub 2024 Oct 14.
With the growing body of research examining the link between sleep disorders, including insomnia and obstructive sleep apnea (OSA), and the gut microbiome, this review seeks to offer a thorough overview of the most significant findings in this emerging field.
Current evidence suggests a complex association between imbalances in the gut microbiome, insomnia, and OSA, with potential reciprocal interactions that may influence each other. Notably, specific gut microbiome species, whether over- or under-abundant, have been associated with variation in both sleep and mood in patients diagnosed with, e.g., major depressive disorder or bipolar disorder. Further studies are needed to explore the potential of targeting the gut microbiome as a therapeutic approach for insomnia and its possible effects on mood. The variability in current scientific literature highlights the importance of establishing standardized research methodologies.
随着越来越多的研究探讨睡眠障碍(包括失眠和阻塞性睡眠呼吸暂停(OSA))与肠道微生物群之间的联系,本综述旨在全面概述这一新兴领域的最重要发现。
目前的证据表明,肠道微生物群失衡、失眠和OSA之间存在复杂的关联,可能存在相互影响的潜在交互作用。值得注意的是,特定的肠道微生物物种,无论是数量过多还是过少,都与被诊断患有例如重度抑郁症或双相情感障碍的患者的睡眠和情绪变化有关。需要进一步研究以探索将肠道微生物群作为失眠治疗方法的潜力及其对情绪可能产生的影响。当前科学文献的多样性凸显了建立标准化研究方法的重要性。